Michele Battaglia - Concepedia

Author

Michele Battaglia

Also Known As

BATTAGLIA, MASSIMO, Battaglia Michele, Battaglia, Michele, D Pucello, Ines Barone, M Battaglia, M Battaglía, M F Battaglia, M. BATTAGLIA, M. Battaglia

394

Publications

9.3K

Citations

H-Index

150

Concepts

All Affiliations

University of Bari Aldo Moro University of Foggia European Institute of Oncology Istituti di Ricovero e Cura a Carattere Scientifico University of Naples Federico II

About

Michele Battaglia is an author at University of Bari Aldo Moro specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	70	3.5K
2	Engineering	1	1	37
3	Health Sciences	1	1	96
4	Natural Sciences	1	1	36
5	Public Health	1	1	38

Michele Battaglia

127

Publications

Citations

H-Index

Page 1

	Year	Citations
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma Giuseppe Lucarelli, Vanessa Galleggiante, Monica Rutigliano, Oncotarget Chemoprevention StrategyCancer MetabolomePathologyMetabolic RemodelingReactive Oxygen Species	2015	246
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma Giuseppe Lucarelli, Monica Rutigliano, Fabio Sallustio, Aging	2018	242
Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins Giuseppe Gerna, Maria Grazia Revello, Elena Percivalle, Journal of Clinical Microbiology Primary ImmunodeficiencyHuman Cytomegalovirus ViremiaHcmv ViremiaDiagnostic VirologyClinical Symptoms	1990	177
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma Giuseppe Stefano Netti, Giuseppe Lucarelli, Federica Spadaccino, Aging	2020	167
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment Roberto Tamma, Monica Rutigliano, Giuseppe Lucarelli, Urologic Oncology Seminars and Original Investigations MedicineMetronomic TherapyImmunologyMast CellsPathology	2019	155
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma Giuseppe Lucarelli, Monica Rutigliano, Matteo Ferro, Urologic Oncology Seminars and Original Investigations Tumor BiologyUrologyPoor OutcomeGenitourinary CancerMedicine	2017	154
Bicalutamide Monotherapy Versus Flutamide Plus Goserelin in Prostate Cancer Patients: Results of an Italian Prostate Cancer Project Study Francesco Boccardo, A. Rubagotti, M. Barichello, Journal of Clinical Oncology	1999	149
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics Rosa Ragone, Fabio Sallustio, Sara Piccinonna, Diseases	2016	149
Therapeutic Targeting of Classical and Lectin Pathways of Complement Protects from Ischemia-Reperfusion-Induced Renal Damage Giuseppe Castellano, Rita Melchiorre, Antonia Loverre, American Journal Of Pathology InflammationComplement ProtectsComplement SystemRenal FunctionMedicine	2010	148
Evaluation of Tamoxifen and Anastrozole in the Prevention of Gynecomastia and Breast Pain Induced by Bicalutamide Monotherapy of Prostate Cancer Francesco Boccardo, A. Rubagotti, Michele Battaglia, Journal of Clinical Oncology	2005	144

Page 1